News

The agreement provides an opportunity for Baxter to exclusively develop a new recombinant protein and investigate its potential use in treating unmet medical needs. Under the terms of

Mr Cramer joined Bacchus Vascular earlier this year as senior vice president of sales. Previously he served as senior vice president of US sales and account services for

Ms Briggs has more than two decades of sales, management and consulting experience in the biopharmaceutical industry. Since joining Kendle in 2005 as senior director of strategic accounts,

Former acting US surgeon general and public health expert, Kenneth Moritsugu, will serve as the institute’s chairman. The institute is part of a new effort to address the

The antibody, which was genetically engineered for large-scale production, binds to myelin and the surface of cells in the brain and spinal cord, triggering the cells to begin

The Phase I study was conducted in Israel and enrolled 10 eligible patients undergoing elective partial nephrectomy. The fibrin patch was used in this study as an adjunct

Samaritan received $1.4 million of the $10 million agreement back in March of this year upon the signing of the deal. Pharmaplaz takes financial responsibility for the future

The two Phase III pivotal trials assessed the safety and efficacy of a 6-month course of Puricase (pegloticase) therapy in patients with treatment-failure gout, under the auspices of

Both the in vitro and in vivo studies indicate that small molecule inhibitors of the Id proteins will block angiogenesis and malignant transformation of cells responsible for tumor